Sotrovimab is much less effective against BA.2... - CLL Support
Sotrovimab is much less effective against BA.2 sub variant - possibly 27 times less effective.
You need to be a member of this community to see this post.
9 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
COVID-19 hospitalizations soaring in England.
The UK is assuming that COVID-19 is endemic and that Omicron is mild. But the confluence of BA.2...
FDA updated their guidance offered to healthcare providers concerning Evusheld
Hi,
On October 3, 2022, the FDA updated their guidance offered to healthcare providers concerning...
Combining the Influenza and COVID-19 vaccines.
I have read of some people who got both vaccines at the same time, and their experience was not...
New drug cuts deaths among patients with no Covid antibodies
New drug cuts deaths among patients with no Covid antibodies...
Evusheld-Flu-Covid Injections In Two Weeks Timeframe
15 days ago, I received my second round of Evusheld. It had been 6 months since my first round of...
Does getting annual flu shot help fight against Covid-19?
Leukemia And COVID-19
COVID Vaccination and WBC
COVID, Pneumonia and healthcare
COVID vaccine May 2024
